Alphatec Holdings, Inc. (NASDAQ:ATEC) is among the many finest NASDAQ shares underneath $50 to purchase. On Monday, analysts at Lake Avenue Capital Markets initiated a high-note protection on Aphatec Holdings with a Purchase score and worth goal of $18, implying a strong soar of 63% from its present buying and selling worth of $11.02.
What’s driving the optimistic outlook? As Lake Avenue highlights,
“Alphatec Holdings, Inc. (NASDAQ:ATEC) represents the one scaled backbone participant completely targeted on bettering backbone outcomes whereas a lot of the trade borders on completely confused.”
A medical skilled guiding a robotic device putting pedicle screws in a affected person’s spinal column.
This constructive protection adopted a non-deal roadshow in New York Metropolis, the place Alphatec’s administration and Lake Avenue analysts met to debate the corporate’s targets and strategic plans. The funding financial institution believes that the corporate will proceed to surpass development charges pushed by a deal with a distinct segment backbone therapies market. That is bolstered by the 20.04% year-to-date return delivered by the large in distinction to the return of merely 2.58% by the broader market.
Alphatec Holdings, Inc. (NASDAQ:ATEC) is a California-based medical expertise firm that engages within the design and development of surgical remedy of spinal problems applied sciences. Based in 1990, the core choices of the corporate embody the Alpha InformatiX product platform, VEA alignment cellular utility, and PTP Affected person Positioning Methods. The corporate goals to turn into “The Normal-Bearer in Backbone.”
Whereas we acknowledge the potential of ATEC as an funding, we imagine sure AI shares provide higher upside potential and carry much less draw back danger. For those who’re searching for an especially undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring pattern, see our free report on the finest short-term AI inventory.
READ NEXT: The Greatest and Worst Dow Shares for the Subsequent 12 Months and 10 Unstoppable Shares That May Double Your Cash.
Disclosure: None.
